Brain Scientific Inc. (BRSF) One of Ten Companies Featured in Global Brain Diagnostics Devices Industry Report

• Market expected to progress at CAGR of 9% until 2024, driven by technological advances and the integration of software and analytical tools in brain monitoring devices.
• North American market continues to dominate.
• As a company revolutionizing brain diagnostic devices market, BRSF seems ideally positioned within thriving market.

A recently published report on EEG and EMG devices market shows that the global brain monitoring market is expected to progress at a CAGR of 9%, increasing by more than $740 million from 2019 to 2024 (https://ibn.fm/qinVW). The report highlights that the market is fragmented with several players occupying the market share; the report goes on to feature Brain Scientific (OTCQB: BRSF) as one of 10 companies relevant in the EEG and EMG devices market globally.

The report aims to provide a holistic update to EEG and EMG devices market size offering and provide relevant insights into industry trends and forecasts. Among its findings, the report suggests that the overall impact of the COVID-19 pandemic will be positive on the health-care sector as the industry is expected to register higher growth rate compared to the global economy.

The robust growth of the EEG and EMG devices market, reaching approximately 8.4% in 2020, is mainly generated by the North American market, which tallied 40% of the total.  The study expects the main driving forces for the robust growth of the market — the technological advances and the integration of software and analytical tools in brain monitoring devices — to remain one of the major forces driving the EEG and EMG devices market growth over the next few years.

The integration of software analytics with brain monitoring devices allows automation and standardization of complex monitoring procedures and is used for advanced processing and analysis of raw EEG data. This development aimed at improving patient experience and outcomes is expected to positively impact market growth.

As a commercial-stage, healthcare company providing novel solutions that modernize brain diagnostics, Brain Scientific looks to be ideally positioned to capture the robust growth of the EEG and EMG devices market expected over the next several years. BRSF has developed two easy-to-use, FDA-cleared products: the NeuroCap(TM), a flexible head cap for conducting electroencephalography, and the NeuroEEG(TM), a modern, portable, user-friendly EEG amplifier. Together these two offerings provide cost-effective and disposable substitutes to existing slow, expensive and cumbersome EEG devices, allowing any medical professional to apply EEG in five minutes or less.

Featured in the brain diagnostics market report, Brain Scientific looks to be leading in the growing industry. The company is currently focused on the North American market, which is expected to drive growth over the next several years. With its technology road map, which includes the development of AI-assisted diagnostic analysis to increase neurologist efficiency, consistency and accuracy, BRSF seems in a good place to leverage the momentum of the novel EEG diagnostics market.

For more information, visit the company’s website at www.BrainScientific.com.

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.